标题
Everolimus
作者
关键词
-
出版物
PEDIATRIC DRUGS
Volume 14, Issue 1, Pages 51-60
出版商
Springer Nature
发表日期
2011-12-04
DOI
10.2165/11207730-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors
- (2011) BingHe Xu et al. Journal of Hematology & Oncology
- Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo
- (2010) Terry OʼReilly et al. ANTI-CANCER DRUGS
- The pathophysiology of tuberous sclerosis complex
- (2010) Peter B. Crino EPILEPSIA
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
- (2009) H. A. Lane et al. CLINICAL CANCER RESEARCH
- Everolimus
- (2009) Karly P. Garnock-Jones et al. DRUGS
- The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines
- (2009) Brigette B. Y. Ma et al. INVESTIGATIONAL NEW DRUGS
- Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors
- (2009) I. Okamoto et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis
- (2009) Kristen Pollizzi et al. Molecular Cancer
- Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
- (2008) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors
- (2008) Anne O'Donnell et al. JOURNAL OF CLINICAL ONCOLOGY
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Current Management of Tuberous Sclerosis Complex
- (2008) Darcy A Krueger et al. PEDIATRIC DRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now